Researchers projected that adult obesity rates in the U.S. will rise to 47% in the next decade. Multifactorial strategies ...

Otsuka Pharmaceutical announced that the FDA is reviewing investigational centanafadine -- a potential first-in-class ...

During the pandemic, rates of Staphylococcus aureus did not decrease (aRR 1.17, 95% CI 0.89-1.55), and rates of bloodstream ...

Dozens of commonly used medications, both prescription and over-the-counter (OTC), can adversely affect ICI activity and ...

For papers submitted to JAMA Network journals, the most commonly disclosed use of AI was for correction or refinement of ...

Rogue researchers managed to access genetic data from 20,000 U.S. kids, which they used to do bogus 'race science' research, ...

An estimated 31,000 registered nurses and other frontline Kaiser Permanente healthcare workers launched an open-ended strike ...

Promising new approaches to treating gastric cancer have emerged in recent years. These treatments aim to increase patient ...

In other FDA news, the agency approved daratumumab and hyaluronidase (Darzalex Faspro) in combination with bortezomib ...

In a matched analysis, use of the dual GIP/GLP-1 receptor agonist was associated with reduced 12-month risks of diabetic ...

The second round of price negotiations covered 15 drugs and included household names such as semaglutide (Ozempic, Rybelsus, ...